Northeast Pharmaceutical (000597.SZ): Mabalosavir API marketing application approved

Zhitongcaijing · 1d ago

Zhitong Finance App News, Northeast Pharmaceutical (000597.SZ) issued an announcement. Recently, the company received the “Notice of Approval of Application for the Marketing of Chemical Ingredients” approved and issued by the State Drug Administration, and the company's application for the marketing of mabalosavir APIs was approved. Mabalosavir preparations are suitable for previously healthy adults and children aged 5 and above with simple influenza A and B, or influenza patients in adults and children aged 12 and above who are at high risk of influenza-related complications.